Clinical Trial Update: Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention [NA]

View source ↗

Summary

A clinical trial at University Hospital, Bordeaux is identifying metabolic signatures of atrial fibrillation to enable personalized prevention strategies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Atrial Fibrillation (AF) | NA | Status: RECRUITING